Imperial College London is a public research university located in London. In 1907, Imperial College was established by royal charter, merging the Royal College of Science, Royal School of Mines, and City and Guilds of London Institute. In 1988, the Imperial College School of Medicine was formed by combining with St. Mary’s hospital. The main campus is located in South Kensington, with an innovation campus in White City. The college also has teaching hospitals throughout London. The university focuses exclusively on science, engineering, medicine, and business. Imperial has an international community, with more than 59% of students from outside the UK and 140 countries represented on campus. In 2019–20, Imperial is globally ranked 9th in the Times Higher Education World University Rankings, 9th in the QS World University Rankings, 24th in the Academic Ranking of World Universities, and 8th in Reuters The World’s Most Innovative Universities. Main tasks in the project – ICL will perform all the lipidomics detailed in the proposal (WP2-5).
Prof. Dr. Julian Griffin focuses on the development of metabolomics and lipidomics tools to investigate aspects of the Metabolic Syndrome (http://www.bioc.cam.ac.uk/uto/griffin.html). In addition he has a long standing interest in the use of lipidomics and metabolomics as a tool for toxicology. His group has been at the centre of the development of metabolomics/metabonomics as a research tool in biochemistry, particularly its application to medical diagnostics, personalised medicine and toxicology.
Dr. Sonia Liggi is an expert in bioinformatics and will provide training in aspects of computational biology and bioinformatics using R, python, galaxy and Knime workflows.
Dr. Susy Palma Duran is an expert in mass spectrometry based metabolomics, particularly using mass spectrometry.